A Pre-Conference Program; additional registration was required
CAR T treatments have led to improved outcomes for patients with hematologic malignancies. However, the same level of success has not been achieved in most solid tumors, and other immune cell types beyond T cells are also being explored preclinically and clinically. This workshop highlighted the multitude of cellular therapy approaches being applied for the treatment of cancer, including many T cell strategies, alternative immune cells, practical considerations and novel technologies.
Monday, Nov. 9, 2020*
9 a.m. - 2:55 p.m. EST
*Dates and times subject to change.
- Christine Brown, PhD – City of Hope
- Katy Rezvani, MD, PhD – The University of Texas MD Anderson Cancer Center
- Marco Ruella, MD – University of Pennsylvania
SITC's Workshop in Engineering Immune Cells for Cancer Therapy is supported in part by grants from Bristol Myers Squibb and Genentech, a member of the Roche Group.
*Program schedule subject to change.